Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alpine Immune Sciences Inc (ALPN)

Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alpine Immune Sciences Inc 188 East Blaine Street Suite 200 Seattle WA 98102 USA

www.alpineimmunesciences.com P: 206-788-4545

Description:

Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 4,456,812
Enterprise Value, $K 4,412,892
Shares Outstanding, K 68,598
Annual Sales, $ 58,880 K
Annual Net Income, $ -32,180 K
Last Quarter Sales, $ 7,030 K
Last Quarter Net Income, $ -17,920 K
EBIT, $ -51,360 K
EBITDA, $ -58,830 K
60-Month Beta 0.97
% of Insider Shareholders 42.30%
% of Institutional Shareholders 75.17%
Float, K 39,581
% Float 57.70%
Short Volume Ratio 0.72

Growth:

1-Year Return 657.23%
3-Year Return 442.77%
5-Year Return 1,253.54%
5-Year Revenue Growth 8,192.96%
5-Year Earnings Growth 75.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 05/09/24
Next Earnings Date N/A
Earnings Per Share ttm -0.64
EPS Growth vs. Prev Qtr -286.67%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 07/25/17

ALPN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -14.86%
Return-on-Assets % -11.82%
Profit Margin % -54.65%
Debt/Equity 0.00
Price/Sales 75.69
Price/Cash Flow N/A
Price/Book 12.80
Book Value/Share 5.07
Interest Coverage -319.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar